AVE 0.00% 0.2¢ avecho biotechnology limited

incredible, page-34

  1. 5,797 Posts.
    lightbulb Created with Sketch. 736
    As another aside -
    The nestle topic still intrigues me.
    They halted progress because nesltes end points were not met in treating metabolic syndrome with phospa e. Please correct that if I'm wrong.

    I never saw that as a fault of TPM, more as vitamin e's ability to effect those endpoints.

    I rare time when poh/partner was testing a drug and it's effects coupled with tpm, requiring tpm to work but also the active to work.
    Most other products oxy, insulin etc is known to already work, so it's all about the transfer efficiency.

    Anyway, that's probably a discussion for another day.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.